YM155 Induces EGFR Suppression in Pancreatic Cancer Cells

• Young-Soon Na,

  Affiliation Institute for Innovate Cancer Research, Asan Medical Center, Seoul, Korea

  ⨯
• Soo-Jin Yang,

  Affiliation Institute for Innovate Cancer Research, Asan Medical Center, Seoul, Korea

  ⨯
• Seung-Mi Kim,

  Affiliation Institute for Innovate Cancer Research, Asan Medical Center, Seoul, Korea

  ⨯
• Kyung-Ah Jung,

  Affiliation Institute for Innovate Cancer Research, Asan Medical Center, Seoul, Korea

  ⨯
• Jai-Hee Moon,

  Affiliation Institute for Innovate Cancer Research, Asan Medical Center, Seoul, Korea

  ⨯
• Jae-Sik Shin,

  Affiliation Institute for Innovate Cancer Research, Asan Medical Center, Seoul, Korea

  ⨯
• Dok Hyun Yoon,

  Affiliation Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

  ⨯
• Yong Sang Hong,

  Affiliations Institute for Innovate Cancer Research, Asan Medical Center, Seoul, Korea, Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

  ⨯
• Min-Hee Ryu,

  Affiliation Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

  ⨯
• Jae-Lyun Lee,

  Affiliations Institute for Innovate Cancer Research, Asan Medical Center, Seoul, Korea, Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

  ⨯
• Jung Shin Lee,

  Affiliations Institute for Innovate Cancer Research, Asan Medical Center, Seoul, Korea, Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

  ⨯
• Tae Won Kim

  * E-mail: twkimmd@amc.seoul.kr

  Affiliations Institute for Innovate Cancer Research, Asan Medical Center, Seoul, Korea, Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

  ⨯